Prestige Consumer Healthcare Inc. (NYSE:PBH) EVP Sells $743,166.00 in Stock

Prestige Consumer Healthcare Inc. (NYSE:PBH) EVP Adel Mekhail sold 9,063 shares of Prestige Consumer Healthcare stock in a transaction dated Tuesday, November 12th. The stock was sold at an average price of $82.00, for a total value of $743,166.00. Following the completion of the transaction, the executive vice president now owns 18,365 shares in the company, valued at $1,505,930. The trade was a 33.04 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website.

Prestige Consumer Healthcare Trading Down 0.5 %

Shares of PBH opened at $82.36 on Friday. Prestige Consumer Healthcare Inc. has a 12-month low of $56.61 and a 12-month high of $83.83. The company has a quick ratio of 2.10, a current ratio of 3.56 and a debt-to-equity ratio of 0.61. The firm has a market capitalization of $4.07 billion, a price-to-earnings ratio of 20.04, a P/E/G ratio of 2.32 and a beta of 0.47. The stock’s 50-day moving average price is $73.29 and its 200 day moving average price is $70.25.

Prestige Consumer Healthcare (NYSE:PBH) last issued its quarterly earnings results on Thursday, November 7th. The company reported $1.09 earnings per share (EPS) for the quarter, meeting the consensus estimate of $1.09. The firm had revenue of $283.79 million for the quarter, compared to analyst estimates of $282.09 million. Prestige Consumer Healthcare had a return on equity of 12.23% and a net margin of 18.54%. The company’s quarterly revenue was down .9% compared to the same quarter last year. During the same period in the previous year, the company posted $1.07 earnings per share. As a group, research analysts predict that Prestige Consumer Healthcare Inc. will post 4.45 earnings per share for the current year.

Analyst Upgrades and Downgrades

PBH has been the topic of a number of recent analyst reports. Jefferies Financial Group reiterated a “hold” rating and issued a $76.00 price objective (up from $70.00) on shares of Prestige Consumer Healthcare in a research note on Tuesday, September 24th. DA Davidson reiterated a “buy” rating and issued a $95.00 price objective on shares of Prestige Consumer Healthcare in a research note on Monday, November 11th. One research analyst has rated the stock with a hold rating and three have assigned a buy rating to the company. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $83.67.

Institutional Investors Weigh In On Prestige Consumer Healthcare

Institutional investors have recently added to or reduced their stakes in the stock. Opal Wealth Advisors LLC acquired a new stake in Prestige Consumer Healthcare during the second quarter valued at approximately $26,000. Quest Partners LLC boosted its holdings in Prestige Consumer Healthcare by 2,826.7% during the second quarter. Quest Partners LLC now owns 439 shares of the company’s stock valued at $30,000 after purchasing an additional 424 shares in the last quarter. EverSource Wealth Advisors LLC boosted its holdings in Prestige Consumer Healthcare by 80.6% during the first quarter. EverSource Wealth Advisors LLC now owns 466 shares of the company’s stock valued at $33,000 after purchasing an additional 208 shares in the last quarter. Northwestern Mutual Wealth Management Co. boosted its holdings in shares of Prestige Consumer Healthcare by 562.3% in the 2nd quarter. Northwestern Mutual Wealth Management Co. now owns 510 shares of the company’s stock worth $35,000 after acquiring an additional 433 shares in the last quarter. Finally, Gladius Capital Management LP acquired a new position in shares of Prestige Consumer Healthcare in the 2nd quarter worth approximately $35,000. 99.95% of the stock is owned by institutional investors and hedge funds.

Prestige Consumer Healthcare Company Profile

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.